InMed Pharmaceuticals Inc. (INM) shareholders
Close on Oct 19, 2026Market cap $96.14MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Daniel Schneeberger Joint filing with ADAR1 Capital Management, LLC (17.20%) | 943,668 | 17.20% | 13G (passive) amendment | Sep 30, 2026 |
| Vivo Opportunity Fund Holdings, L.P. Joint filing with Vivo Opportunity, LLC (21.70%) | 718,444 | 21.70% | 13D (active) | May 19, 2026 |
| William Blank Joint filing with Squadron Master Fund LP (9.80%), Squadron Capital Management LLC (9.80%) and 1 more | 325,000 | 9.80% | 13G (passive) | May 19, 2026 |
| Sabby Volatility Warrant Master Fund, Ltd. Joint filing with Sabby Management, LLC (9.90%), Hal Mintz (9.90%) | 280,138 | 9.90% | 13G (passive) | Dec 31, 2025 |
| YA II PN, Ltd. Joint filing with YA Global Investments II (U.S.), LP (9.99%), Yorkville Advisors Global, LP (9.99%) and 5 more | 80,372 | 9.99% | 13G (passive) | Dec 13, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of INM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 800,000 | – | $1.24M | New | 0.06% |
| Vivo Capital, LLC | 798,377 | – | $1.24M | New | 0.11% |
| Squadron Capital Management LLC | 325,000 | – | $503.75K | New | 0.16% |
| Ikarian Capital, LLC | 245,025 | – | $379.79K | New | 0.04% |
| Ursa Fund Management, LLC | 125,800 | – | $194.99K | New | 0.02% |
| Suvretta Capital Management, LLC | 100,000 | – | $155.00K | New | 0.00% |
| Boothbay Fund Management, LLC | 74,244 | – | $115.08K | New | 0.00% |
| Sabby Management, LLC | 44,970 | – | $69.70K | −175,290 | 0.06% |
| Jane Street Group, LLC | 43,078 | – | $66.77K | New | 0.00% |
| VR Adviser, LLC | 32,685 | – | $50.66K | New | 0.00% |
| Citadel Advisors LLC | 26,084 | – | $40.43K | −20,889 | 0.00% |
| Seven Grand Managers, LLC | 25,000 | – | $38.75K | New | 0.00% |
| Scientech Research LLC | 15,461 | – | $23.97K | New | 0.02% |
| Crestwood Advisors Group LLC | 14,900 | – | $23.10K | New | 0.00% |
| Two Sigma Securities, LLC | 10,945 | – | $16.97K | −7,773 | 0.00% |
| Stratos Wealth Partners, LTD. | 10,760 | – | $16.68K | New | 0.00% |
| Private Wealth Management Group, LLC | 5,000 | – | $7.75K | – | 0.00% |
| SBI Securities Co., Ltd. | 300 | – | $465 | – | 0.00% |
| Banque Cantonale Vaudoise | 6 | – | $1.00M | – | 0.00% |
| Federation des caisses Desjardins du Quebec | 2 | – | $4 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 20 | 3M | 13 / 0 | 3 / 2 | 3M | 0M |
| Q1 2026 | 9 | 0M | 4 / 2 | 0 / 2 | 0M | 0M |
| Q4 2025 | 7 | 0M | 3 / 0 | 1 / 4 | 0M | 0M |
| Q3 2025 | 9 | 0M | 5 / 1 | 0 / 3 | 0M | 0M |
| Q2 2025 | 7 | 0M | 2 / 1 | 0 / 0 | 0M | 0M |
| Q1 2025 | 5 | 0M | 2 / 0 | 1 / 2 | 0M | 0M |
| Q4 2024 | 5 | 0M | 5 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1 funds held INM in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of INM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund | 6,495 | – | $10.07K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Gregory J. Divis | See Remarks, Director | – | Nov 12, 2026 |
| Eric A. Adams | President & CEO, Director | 58,894 | Dec 19, 2025 |
| Jerad G. Seurer | See Remarks | – | Nov 12, 2026 |
| Brett R. Hagen | See Remarks | – | Nov 12, 2026 |
| Netta Jagpal | Chief Financial Officer | – | Dec 19, 2025 |
| Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 1,273 | Dec 19, 2025 |
| Michael Woudenberg | Chief Operating Officer | 530 | Dec 19, 2025 |
| Shane Aaron Johnson | Sr VP & General Manager | 583,023 | Dec 19, 2025 |
| Michelle Patricia Pernice | Director | 27,868 | Nov 12, 2026 |
| Julianne Bruno | Director | 33,442 | Nov 12, 2026 |
| Laura Lee Sandler | Director | – | Nov 12, 2026 |
| Todd Shegog | Director | – | Nov 12, 2026 |
| John Steven Bathery | Director | – | Dec 19, 2025 |
| Nicole Lemerond | Director | – | Dec 19, 2025 |
| Neil A. Klompas | Director | – | Dec 19, 2025 |
| Andrew Hull | Director | 38,258 | Dec 19, 2025 |
| Janet P. Grove | Director | – | Dec 23, 2024 |
| Bryan T. Baldasare | Director | – | Dec 23, 2024 |
| Tomas Kiselak | 10% owner | – | Nov 12, 2026 |
| Peter Evan Harwin | 10% owner | – | Nov 12, 2026 |
| Healthcare Fund II L.P. Fairmount | 10% owner | – | Nov 12, 2026 |
| Funds Management LLC Fairmount | 10% owner | 10,555,507 | Nov 12, 2026 |
| ADAR1 Capital Management, LLC | 10% owner | 98,297 | Nov 9, 2026 |
| Daniel Schneeberger | 10% owner | 892,101 | Nov 9, 2026 |
| Vivo Opportunity Cayman, LLC | 10% owner | – | Jul 16, 2026 |
| Vivo Opportunity, LLC | 10% owner | 797,530 | Jul 16, 2026 |
| Vivo Opportunity Fund Holdings, L.P. | 10% owner | 541,752 | Jul 16, 2026 |
| Vivo Opportunity Cayman Fund, L.P. | 10% owner | 818,076 | Jul 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC 10% owner | Nov 5, 2026 | Buy | +2,640 | $13.10 | $34.57K | 98,297 |
| ADAR1 Capital Management, LLC 10% owner | Oct 23, 2026 | Buy | +4 | $1.32 | $5 | 956,584 |
| ADAR1 Capital Management, LLC 10% owner | Oct 19, 2026 | Buy | +1,086 | $1.32 | $1.43K | 956,580 |
| ADAR1 Capital Management, LLC 10% owner | Oct 16, 2026 | Buy | +1 | $1.32 | $1 | 955,494 |
| ADAR1 Capital Management, LLC 10% owner | Oct 15, 2026 | Buy | +984 | $1.32 | $1.30K | 955,493 |
| ADAR1 Capital Management, LLC 10% owner | Oct 14, 2026 | Buy | +8,021 | $1.33 | $10.67K | 954,509 |
| ADAR1 Capital Management, LLC 10% owner | Oct 13, 2026 | Buy | +564 | $1.33 | $750 | 946,488 |
| ADAR1 Capital Management, LLC 10% owner | Oct 8, 2026 | Buy | +2,256 | $1.33 | $3.00K | 945,924 |
| ADAR1 Capital Management, LLC 10% owner | Oct 7, 2026 | Buy | +3,046 | $1.33 | $4.05K | 943,668 |
| ADAR1 Capital Management, LLC 10% owner | Oct 6, 2026 | Buy | +5,601 | $1.33 | $7.44K | 940,622 |
| ADAR1 Capital Management, LLC 10% owner | Oct 5, 2026 | Buy | +18,182 | $1.33 | $24.18K | 935,021 |
| ADAR1 Capital Management, LLC 10% owner | Oct 2, 2026 | Buy | +8,307 | $1.33 | $11.05K | 916,839 |
| ADAR1 Capital Management, LLC 10% owner | Oct 1, 2026 | Buy | +16,431 | $1.33 | $21.85K | 908,532 |
| Daniel Schneeberger 10% owner | Sep 16, 2026 | Buy | +8,340 | $1.29 | $10.76K | 892,101 |
| Daniel Schneeberger 10% owner | Sep 15, 2026 | Buy | +54,256 | $1.30 | $70.53K | 883,761 |
| Daniel Schneeberger 10% owner | Sep 14, 2026 | Buy | +28,505 | $1.29 | $36.77K | 829,505 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 16, 2026 | Buy | +19 | $1.55 | $29 | 743,057 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 16, 2026 | Buy | +2 | $1.55 | $3 | 75,019 |
| ADAR1 Capital Management, LLC 10% owner | Jul 15, 2026 | Buy | +1,000 | $1.56 | $1.56K | 801,000 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 15, 2026 | Buy | +13,761 | $1.55 | $21.33K | 743,038 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 15, 2026 | Buy | +1,389 | $1.55 | $2.15K | 75,017 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 14, 2026 | Buy | +4,882 | $1.55 | $7.57K | 729,277 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 14, 2026 | Buy | +493 | $1.55 | $764 | 73,628 |
| Vivo Opportunity, LLC 10% owner | Jul 2, 2026 | Buy | +1,460 | $1.55 | $2.26K | 724,395 |
| Vivo Opportunity, LLC 10% owner | Jul 2, 2026 | Buy | +147 | $1.55 | $228 | 73,135 |
| Vivo Opportunity, LLC 10% owner | Jul 1, 2026 | Buy | +3,946 | $1.55 | $6.12K | 722,935 |
| Vivo Opportunity, LLC 10% owner | Jul 1, 2026 | Buy | +398 | $1.55 | $617 | 72,988 |
| Vivo Opportunity, LLC 10% owner | Jun 30, 2026 | Buy | +55 | $1.54 | $85 | 72,590 |
| Vivo Opportunity, LLC 10% owner | Jun 30, 2026 | Buy | +545 | $1.54 | $839 | 718,989 |
| Vivo Opportunity, LLC 10% owner | Jun 8, 2026 | Buy | +29,518 | $1.52 | $44.87K | 718,444 |
| Vivo Opportunity, LLC 10% owner | Jun 8, 2026 | Buy | +2,982 | $1.52 | $4.53K | 72,535 |
| Vivo Opportunity, LLC 10% owner | Jun 5, 2026 | Buy | +5,045 | $1.57 | $7.92K | 69,553 |
| Vivo Opportunity, LLC 10% owner | Jun 5, 2026 | Buy | +49,966 | $1.57 | $78.45K | 688,926 |
| Vivo Opportunity, LLC 10% owner | Jun 4, 2026 | Buy | +618 | $1.57 | $970 | 64,508 |
| Vivo Opportunity, LLC 10% owner | Jun 4, 2026 | Buy | +6,125 | $1.57 | $9.62K | 638,960 |
| Vivo Opportunity, LLC 10% owner | Jun 3, 2026 | Buy | +714 | $1.55 | $1.11K | 63,890 |
| Vivo Opportunity, LLC 10% owner | Jun 3, 2026 | Buy | +7,069 | $1.55 | $10.96K | 632,835 |
| Vivo Opportunity, LLC 10% owner | Jun 2, 2026 | Buy | +2,095 | $1.52 | $3.18K | 63,176 |
| Vivo Opportunity, LLC 10% owner | Jun 2, 2026 | Buy | +20,753 | $1.52 | $31.54K | 625,766 |
| Vivo Opportunity, LLC 10% owner | Jun 1, 2026 | Buy | +1,498 | $1.55 | $2.32K | 61,081 |
| Vivo Opportunity, LLC 10% owner | Jun 1, 2026 | Buy | +14,838 | $1.55 | $23.00K | 605,013 |
| Vivo Opportunity, LLC 10% owner | May 29, 2026 | Buy | +1,632 | $1.57 | $2.56K | 59,583 |
| Vivo Opportunity, LLC 10% owner | May 29, 2026 | Buy | +16,164 | $1.57 | $25.38K | 590,175 |
| Vivo Opportunity, LLC 10% owner | May 21, 2026 | Buy | +3,118 | $1.69 | $5.27K | 57,951 |
| Vivo Opportunity, LLC 10% owner | May 21, 2026 | Buy | +30,882 | $1.69 | $52.19K | 574,011 |
| Vivo Opportunity, LLC 10% owner | May 20, 2026 | Buy | +5,154 | $1.56 | $8.04K | 54,833 |
| Vivo Opportunity, LLC 10% owner | May 20, 2026 | Buy | +51,056 | $1.56 | $79.65K | 543,129 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +200,000 | $1.50 | $300.00K | 800,000 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +200,000 | $1.56 | $312.00K | 600,000 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +68,551 | $1.60 | $109.68K | 400,000 |
| Alexandra Diane Janet Mancini – | Jul 31, 2024 | Sale | −240 | $0.18 | $43 | 0 |
| Andrew Hull Director | Feb 21, 2024 | Buy | +37,500 | $0.39 | $14.63K | 38,258 |
| Eric A. Adams President & CEO, Director | Feb 20, 2024 | Buy | +41,600 | $0.36 | $14.98K | 43,959 |
| Eric A. Adams President & CEO, Director | Apr 14, 2022 | Buy | +14,160 | $0.89 | $12.60K | 59,003 |
| Eric A. Adams President & CEO, Director | Apr 13, 2022 | Buy | +8,560 | $0.85 | $7.28K | 44,843 |
| Bruce Colwill CFO | Jan 24, 2022 | Buy | +5,000 | $1.09 | $5.45K | 11,515 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Jan 6, 2022 | Buy | +8,500 | $1.26 | $10.71K | 304,595 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Dec 30, 2021 | Buy | +8,093 | $1.33 | $10.76K | 296,095 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Nov 15, 2021 | Buy | +5,000 | $1.37 | $6.85K | 288,002 |
| Eric A. Adams President & CEO, Director | Sep 29, 2021 | Buy | +8,800 | $1.73 | $15.22K | 36,283 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of InMed Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 36,285 shares on Sep 4, 2026 over the last 90 days.
See a number that looks wrong?